CD274 and colonic neoplasm: Other potential predictive biomarkers which are proposed in colon cancer immunotherapy include PD-L1 expression level, tumor mutation burden (TMB), tumor-infiltrating lymphocytes (TILs), gut microbiota, ctDNA, and circulating immune cells (20–24).